MPWR vs NVDA

MPWR demonstrates exceptional operational health with a Piotroski F-Score of 7/9 and a nearly debt-free balance sheet (Debt/Equity 0.01). However, there is a massive disconnect between the current market price ($1363.42) and deterministic value markers, specifically the Graham Number ($144.61) and Intrinsic Value ($89.74). While the company maintains a stellar 25-quarter earnings beat record and strong revenue growth, the valuation is extreme (P/E 106.35, P/S 24.00). This fundamental strength is currently offset by heavy insider selling and a sharply bearish technical trend, suggesting the stock is significantly overextended.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.